Department of Emergency Medicine, Research Centre, CIUSSS-Nord-de-l'Île de-Montréal, Hôpital Sacré-Cœur de Montréal, Montréal, Québec, Canada; Département Médecine de Famille et Médecine d'Urgence, Faculté de Médecine, Université de Montréal, Montréal, Québec, Canada; Research Centre, CIUSSS-Nord-de-l'Île de-Montréal, Hôpital Sacré-Cœur de Montréal, Montréal, Québec, Canada.
Department of Emergency Medicine, Research Centre, CIUSSS-Nord-de-l'Île de-Montréal, Hôpital Sacré-Cœur de Montréal, Montréal, Québec, Canada; Centre for Advanced Research in Sleep Medicine, Hôpital du Sacré-Coeur de Montréal (CIUSSS du Nord de-l'Île-de-Montréal), Montréal, Québec, Canada.
Am J Emerg Med. 2022 Feb;52:137-142. doi: 10.1016/j.ajem.2021.11.041. Epub 2021 Dec 4.
Analgesia with fentanyl can be associated with hyperalgesia (higher sensitivity to pain) and can contribute to escalating opioid use. Our objective was to assess the relationship between emergency department (ED) acute pain management with fentanyl compared to other opioids, and the quantity of opioids consumed two-week after discharge. We hypothesized that the quantity of opioids consumed would be higher for patients treated with fentanyl compared to those treated with other opioids.
Patients were selected from two prospective cohorts assessing opioids consumed after ED discharge. Patients ≥18 years treated with an opioid in the ED for an acute pain condition (≤2 weeks) and discharged with an opioid prescription were included. Patients completed a 14-day paper or electronic diary of pain medication use. Quantity of 5 mg morphine equivalent tablets consumed during a 14-day follow-up by patients treated with fentanyl compared to those treated with other opioids during their ED stay were analyzed using a multiple linear regression and propensity scores.
We included 707 patients (mean age ± SD: 50 ± 15 years, 47% women) in this study. During follow-up, patients treated with fentanyl (N = 91) during their ED stay consumed a median (IQR) of 5.8 (14) 5 mg morphine equivalent pills compared to 7.0 (14) for those treated with other opioids (p = 0.05). Results were similar using propensity score sensitivity analysis. However, after adjusting for confounding variables, ED fentanyl treatment showed a trend, but not a statistically significant association with a decreased opioid consumption during the 14-day follow-up (B = -2.4; 95%CI = -5.3 to 0.4; p = 0.09).
Patients treated with fentanyl during ED stay did not consume more opioids after ED discharge, compared to those treated with other opioids. If fentanyl does cause more hyperalgesia compared to other opioids, it does not seem to have a significant impact on opioid consumption after ED discharge.
芬太尼镇痛可能与痛觉过敏(对疼痛的敏感性更高)有关,并可能导致阿片类药物使用的增加。我们的目的是评估急诊(ED)中使用芬太尼与其他阿片类药物进行急性疼痛管理与出院后两周内阿片类药物消耗之间的关系。我们假设,与接受其他阿片类药物治疗的患者相比,接受芬太尼治疗的患者消耗的阿片类药物量会更高。
从评估 ED 出院后阿片类药物消耗的两个前瞻性队列中选择患者。纳入年龄≥18 岁,ED 期间因急性疼痛(≤2 周)接受阿片类药物治疗且出院时开具阿片类药物处方的患者。患者完成了为期 14 天的纸质或电子疼痛药物使用日记。通过多线性回归和倾向评分分析,比较接受芬太尼治疗的患者(n=91)和接受其他阿片类药物治疗的患者(n=707)在 ED 住院期间的 14 天随访期间消耗的 5mg 吗啡等效片数量。
本研究共纳入 707 例患者(平均年龄±标准差:50±15 岁,47%为女性)。在随访期间,接受芬太尼治疗的患者(n=91)在 ED 住院期间消耗的中位数(IQR)为 5.8(14)5mg 吗啡等效片,而接受其他阿片类药物治疗的患者为 7.0(14)(p=0.05)。采用倾向评分敏感性分析得到的结果相似。然而,在校正混杂变量后,ED 芬太尼治疗显示出一种趋势,但与 14 天随访期间阿片类药物消耗减少无统计学显著关联(B=-2.4;95%CI=-5.3 至 0.4;p=0.09)。
与接受其他阿片类药物治疗的患者相比,ED 住院期间接受芬太尼治疗的患者出院后消耗的阿片类药物并不多。如果芬太尼与其他阿片类药物相比确实会引起更多的痛觉过敏,那么它似乎不会对 ED 出院后阿片类药物的消耗产生显著影响。